Menu

Novartis has updated its 340B contract pharmacy restrictions policy to exempt Washington state hospitals and prohibit covered entities’ use of alternative distribution models.

Novartis Exempts Wash. from CP Restrictions, Bans Alt. Distribution Models

June 18, 2026 Shannon Young, Managing Editor 340B Report Views

A Swiss pharmaceutical giant recently updated its 340B contract pharmacy restrictions policy to exempt Washington state hospitals and prohibit covered [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Plenful 340B Solution–340B Referral Agent

GOP Critics Take Another Swipe at 340B After Fox News Highlights Fla. Fraud Case